NuVasive Revenue and Competitors
Estimated Revenue & Valuation
- NuVasive's estimated annual revenue is currently $1.1B per year.
- NuVasive's estimated revenue per employee is $399,011
- NuVasive's total funding is $65.3M.
- NuVasive's current valuation is $2.9B. (January 2022)
Employee Data
- NuVasive has 2832 Employees.
- NuVasive grew their employee count by -8% last year.
NuVasive's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff and Executive Assistant to the CEO | Reveal Email/Phone |
2 | Regional VP, West | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | Commercial VP, Central US | Reveal Email/Phone |
5 | VP | Reveal Email/Phone |
6 | VP, Commercial | Reveal Email/Phone |
7 | SVP Global Operations | Reveal Email/Phone |
8 | SVP, U.S. Commercial | Reveal Email/Phone |
9 | VP Global Quality | Reveal Email/Phone |
10 | VP Capital Technology Sales | Reveal Email/Phone |
NuVasive Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $26M | 163 | -9% | N/A | N/A |
What Is NuVasive?
NuVasive, Inc., headquartered in San Diego, is a privately held medical device company that designs, manufactures & markets minimal access surgery (MAS) systems for the spine. Company is focused on surgeon-driven MAS product designs for the safe & reproducible treatment of degenerative disc disease through spine fusion techniques & non-fusion alternatives that benefit both patient & clinician. The Company\'s MAS technology is facilitating the transfer of today\'s hospital-based procedures to the outpatient setting, reducing costs & operative time while improving surgical outcomes. NuVasive\'s MAS spine surgery products include the NeuroVision(TM) Neurophysiologic Guidance System & peripheral instruments, INS-1(TM) Screw Test System, Triad(TM) Lumbar & Cervical Interbody allograft products, the Hemi-Arc(TM) Surgical Navigator, and specialized working instruments and implants. The Company commercialized its products in 2001.
keywords:Biotechnology, Healthcare
$65.3M
Total Funding
2832
Number of Employees
$1.1B
Revenue (est)
-8%
Employee Growth %
$2.9B
Valuation
N/A
Accelerator
NuVasive News
NuVasive Simplify Cervical Disc Two-level Data Published in Journal of Neurosurgery: Spine. NUVA | 1 hour ago. Peer-reviewed results from the two-level...
SAN DIEGO, April 21, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming...
SAN DIEGO, April 20, 2022 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery...
SAN DIEGO, Sept. 1, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced new executive leadership roles, strengthening its innovation an ...
SAN DIEGO, July 30, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that it received its latest U.S. Food and Drug Administration 5 ...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1155.9M | 3058 | -12% | N/A |
#2 | $1306.6M | 3060 | 6% | N/A |
#3 | $626.5M | 3086 | 5% | N/A |
#4 | $300M | 3456 | N/A | N/A |
#5 | $677.4M | 3456 | 5% | N/A |